OraSure Technologies, Inc. (OSUR)

Market Cap	261.05M
Revenue (ttm)	185.83M
Net Income (ttm)	-19.50M
Shares Out	74.80M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	754,246
Open	3.615
Previous Close	3.660
Day's Range	3.470 - 3.635
52-Week Range	2.690 - 6.380
Beta	-0.02
Analysts	Hold
Price Target	5.50 (+57.59%)
Earnings Date	May 7, 2025

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company’s products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid te...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 501
• Stock Exchange: NASDAQ
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Analyst Forecast

According to 2 analysts, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 57.59% from the latest price.

Price Target

$5.5

(57.59% upside)

Analyst Consensus: Hold